Bruker Posts 2 Percent Q3 Revenue Decline, Will Lay Off 150 in Anticipation of Weak Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker reported today that its revenues in the third quarter were down 2 percent year over year, falling to $439 million from $447.8 million in Q3 2012.

The drop was driven by weakness in the company's Energy and Semiconducting Technologies (BEST) segment, which saw revenue decline by 27 percent in the quarter. Bruker's Scientific Instruments segment, which includes its mass spectrometry and life sciences business, grew a fraction of 1 percent year over year.

The results fell short of the average Wall Street estimate of $452.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.